Your browser doesn't support javascript.
loading
Shear-wave velocity for colorectal cancer liver metastases as a potential prognostic factor after chemotherapy: a preliminary study.
Lee, D H; Lee, J Y; Joo, I; Kim, T-Y; Han, S-W; Lee, K-H.
Afiliação
  • Lee DH; Department of Radiology, Seoul National University Hospital, Jongno-gu, Seoul, 03080, South Korea.
  • Lee JY; Department of Radiology, Seoul National University Hospital, Jongno-gu, Seoul, 03080, South Korea; Institute of Radiation Medicine, Seoul National University College of Medicine, Jongno-gu, Seoul, 03080, South Korea. Electronic address: leejy4u@gmail.com.
  • Joo I; Department of Radiology, Seoul National University Hospital, Jongno-gu, Seoul, 03080, South Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, 03080, South Korea.
  • Han SW; Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, 03080, South Korea.
  • Lee KH; Department of Internal Medicine, Seoul National University Hospital, Jongno-gu, Seoul, 03080, South Korea.
Clin Radiol ; 76(3): 224-232, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33402260
ABSTRACT

AIM:

To evaluate whether shear-wave velocity (SWV) can be used for predicting the prognoses of patients with colorectal cancer liver metastases (CRLMs) after chemotherapy. MATERIALS AND

METHODS:

Our institutional review board approved this prospective study, and written informed consent was obtained. SWV of CRLMs were obtained using point shear-wave elastography using acoustic radiation force impulse from 25 patients prior to and 2, 7, and 14 days after chemotherapy. Progression-free survival (PFS) after chemotherapy was estimated using the Kaplan-Meier method. The Cox proportional hazard regression model was used to determine significant predictive factors for PFS. For measurement reproducibility, an additional 37 patients with CRLMs were enrolled and assessed using intraclass correlation coefficients (ICCs).

RESULTS:

After chemotherapy, 10 and 15 patients were classified into responder and non-responder groups, respectively. The estimated 1- and 3-year PFS values in the whole cohort were 36% and 8%, respectively. A decrease in the SWV value on day 2 relative to the initial value was a significant predictive factor for better PFS outcome (hazard ratio = 0.20, 95% confidence interval = 0.07-0.57, p=0.003). The estimated 1 and 3-year PFS rates were 66.7% and 22.2%, respectively, in nine patients with decreased SWV values on day 2 and significantly higher than 18.8% and 0% of 16 patients with increased SWV values on day 2. The ICC value of SWV of CRLMs in the additional 37 patients was 0.823 (95% CI = 0.685-0.905), indicating good agreement.

CONCLUSION:

SWV values of CRLMs could provide prognostic information in patients with CRLMs treated with chemotherapy, as decreased SWV values on day 2 after chemotherapy was a significant predictive factor for better PFS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Técnicas de Imagem por Elasticidade / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Técnicas de Imagem por Elasticidade / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article